Seroprevalence of herpes simplex virus-2 in kidney transplant recipients: A single-center experience

Iranian Journal of Kidney Diseases

Volumn 4, Issue 2, 2010, Pages 158-161

  Khameneh, Zakieh Rostamzadeh ^a   Sepehrvand, Nariman ^a   Taghizadeh Afshari, Ali ^a   Motazakker, Morteza ^a   Ghafari, Ali ^a   Masudi, Sima ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Herpes simplex virus; Kidney transplantation; Serologic tests

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GRAFT RECIPIENT; HEMODIALYSIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SCHOOL CHILD; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; IRAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 77953172851     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol. 2006;7:13-29.
2. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86:805-12.
3. Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, et al. Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands. Euro Surveill. 2008;13:1-5.
4. Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect. 2005;81:103-7.
5. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008;19:838-41.
6. Khameneh ZR, Sepehrvand N. Survey of hepatitis B status in hemodialysis patients in a training hospital in Urmia, Iran. Saudi J Kidney Dis Transpl. 2008;19:466-9.
7. Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol. 2005;56:71-85.
8. Slifkin M, Doron S, Snydman DR. Viral prophylaxis in organ transplant patients. Drugs. 2004;64:2763-92.
9. Pourmand D, Janbakhsh A, Hamzehi K, Dinarvand F. Seroepide miological study of herpes simplex virus in pregnant women referring to health and care center in Kermanshah (2003-2004) Behbood. 2008;4:462-9.
10. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186:S3-28.
11. Basse G, Mengelle C, Kamar N, et al. Disseminated herpes simplex type-2 (HSV-2) infection after solid-organ transplantation. Infection. 2008;36:62 - 4.
12. Anuradha K, Singh HM, Gopal KV, Rama Rao GR, Ramani TV, Padmaja J. Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals. Indian J Dermatol Venereol Leprol. 2008;74:230-3.
13. White RG, Freeman EE, Orroth KK, et al. Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa. Sex Transm Infect. 2008;84:ii12-8.
14. Glynn JR, Crampin AC, Ngwira BM, Ndhlovu R, Mwanyongo O, Fine PE. Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi. Sex Transm Infect 2008;84:356-60.
15. Naraqi S, Jackson GG, Jonasson O, Yamashiroya HM. Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis. 1977;136:531-40.
16. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296:964-73.
17. Merlino C. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients]. G Batteriol Virol Immunol. 1991;84:41-52. Italian.
18. Neyts J, De Clercq E. Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir. Antiviral Res. 1998;40:53-6.